We’re in the News
Stay informed of Noble in the news as we advance our mission to create advanced drug delivery system trainers for the world’s leading pharmaceutical companies, which, in the end, benefit millions of patients worldwide.
A primary goal of rheumatologists remains alleviating the pain, stiffness and tenderness that mark rheumatoid arthritis (RA). Yet in an era marked by a significant increase in self-injection options, it has become crucial for [...]
Millions of patients worldwide living with rare, debilitating conditions are benefiting from developments in biopharmaceuticals and complex chemical entities as well as novel approaches to drug delivery. For example, many therapeutics administered in a [...]
Chronic illnesses are on the rise, which means there are more and more patients who need to self-inject treatments at home. The problem is that patients who lack confidence in using their drug-delivery device [...]
If you have moderate to severe rheumatoid arthritis (RA), you may have found self-injecting your medication to be a particularly frustrating and painful experience. And it’s easy to see why you might feel that [...]
Participants in a study by the company Noble show that the vast majority of patients—92%—would prefer to bring home a training device to practice with prior to starting self-injection. Noble creates trainers for autoinjectors intended [...]
A new grip-able sleeve for pharmaceutical autoinjector pens makes it easier for patients with reduced dexterity due to rheumatoid arthritis (RA) to handle the medical device and perform self-injections, which can help improve health [...]